Home › Atrial Fibrillation › Michigan › Detroit
Atrial Fibrillation clinical trials in Detroit, MI
6 studies for Atrial Fibrillation are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Henry Ford Health, Detroit
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
RecruitingObservational study
- Henry Ford Health, Detroit
The Fourth Left Atrial Appendage Occlusion Study
Recruiting
- Henry Ford Health System, Detroit
- Henry Ford Health System, Detroit
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
RecruitingPhase 2
- Henry Ford Hospital - Cardiology, Detroit
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Recruiting
- Henry Ford Health Care, Detroit
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
RecruitingObservational study
- Henry Ford, Detroit
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Cleveland, OH17 studies
- Boston, MA17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Chicago, IL12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.